Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
IEEE Transactions on Neural Networks and Learning Systems
|
March 5, 2024
Dual Balanced Class-Incremental Learning With im-Softmax and Angular Rectification
Ruicong Zhi, Yicheng Meng, Junyi Hou, et al.
Biomed Research International
|
September 19, 2022
Predictive Factors for Late-Onset Neurological Deficits in Patients with Posttuberculous Thoracic Kyphosis
Jianquan Zhao, Zhuyun Cai, Yicheng Meng, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
September 17, 2015
Up-regulation of microRNA-16 in Glioblastoma Inhibits the Function of Endothelial Cells and Tumor Angiogenesis by Targeting Bmi-1
Fanfan Chen, Lei Chen, Hua He, et al.
World Neurosurgery
|
January 1, 2022
Analysis of Risk Factors Related to Acute Subarachnoid Hemorrhage After Spinal Surgery
Jianquan Zhao, Heng Jiang, Huan Jiang, et al.
Cellular & Molecular Immunology
|
July 21, 2015
MEK2 is a prognostic marker and potential chemo-sensitizing target for glioma patients undergoing temozolomide treatment
Hua He, Maojin Yao, Wenhao Zhang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
IEEE Transactions on Neural Networks and Learning Systems
|
March 5, 2024
Dual Balanced Class-Incremental Learning With im-Softmax and Angular Rectification
Ruicong Zhi, Yicheng Meng, Junyi Hou, et al.
Biomed Research International
|
September 19, 2022
Predictive Factors for Late-Onset Neurological Deficits in Patients with Posttuberculous Thoracic Kyphosis
Jianquan Zhao, Zhuyun Cai, Yicheng Meng, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
September 17, 2015
Up-regulation of microRNA-16 in Glioblastoma Inhibits the Function of Endothelial Cells and Tumor Angiogenesis by Targeting Bmi-1
Fanfan Chen, Lei Chen, Hua He, et al.
World Neurosurgery
|
January 1, 2022
Analysis of Risk Factors Related to Acute Subarachnoid Hemorrhage After Spinal Surgery
Jianquan Zhao, Heng Jiang, Huan Jiang, et al.
Cellular & Molecular Immunology
|
July 21, 2015
MEK2 is a prognostic marker and potential chemo-sensitizing target for glioma patients undergoing temozolomide treatment
Hua He, Maojin Yao, Wenhao Zhang, et al.
Page
of 1